The regulatory professional then does what only they can do; apply scientific and legal judgment, validate the AI's reasoning ...

Zealand Pharma has signed a multi-target collaboration with Generate Biomedicines to design protein therapeutics for obesity ...

IgniteData and RealTime eClinical Solutions partner to let RealTime's clinical research sites use IgniteData's Archer ...

UK-based OMass Therapeutics has closed an oversubscribed $310 million Series C round to drive its endocrinology and ...

Axoltis’ drug, NX210c, failed to meet clinical endpoints in a Phase II trial – but the company says other readouts are ...

The collaboration will integrate AI more directly into scientific instrumentation, aiming to close the gap between ...

Sponsors trialing drugs in the European Union (EU) will be able to continue seeking input from the European Medicines Agency ...

Study finds Bluesky and X users share clinical trial information differently, which could impact recruitment strategies ...

Susanne Michel, vice president, head of HTA methods and evidence planning at Clinigen, and Michael Epstein, vice president, ...

Monthly insights, guidance alerts and blogs from global life sciences law firms, compiled for you in one place.

The legal experts recently discussed the mechanics of direct-to-patient (DTP) and direct-to-employer (DTE) models.

The company has entered into a definitive agreement to sell a Rare Pediatric Disease Priority Review Voucher (PRV) for $210 ...